During the past decade, Inje University Ilsan Paik Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 2 clinical trials were completed, i.e. on average, 9.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Inje University Ilsan Paik Hospital" #1 sponsor was "Seung-Jung Park" with 9 trials, followed by "Seoul National University Hospital" with 5 trials sponsored, "Chong Kun Dang Pharmaceutical" with 3 trials sponsored, "HK inno.N Corporation" with 3 trials sponsored and "Ajou University School of Medicine" with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Inje University Ilsan Paik Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 11 trials as a collaborator, "Inje University" with 4 trials as a collaborator, "Medtronic" with 4 trials as a collaborator, "Seoul National University Hospital" with 4 trials as a collaborator and "Keimyung University Dongsan Medical Center" with 3 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Inje University Ilsan Paik Hospital" are "Coronary Artery Disease" (15 trials), "Cardiovascular Diseases" (3 trials), "Essential Hypertension" (3 trials), "Multivessel Coronary Artery Disease" (3 trials) and "Chronic Hepatitis B" (2 trials). Many other conditions were trialed in "Inje University Ilsan Paik Hospital" in a lesser frequency.

Most popular intervention types in "Inje University Ilsan Paik Hospital" are "Drug" (14 trials), "Device" (10 trials), "Other" (3 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amlodipine 10mg, Candesartan cilexetil 16mg" (2 trials), "Amlodipine 5mg" (2 trials), "Candesartan cilexetil 16mg" (2 trials), "Clopidogrel" (2 trials) and "Cypher" (2 trials). Other intervention names were less common.

The vast majority of trials in "Inje University Ilsan Paik Hospital" are 38 trials for "All" genders.

Currently, there are NaN active trials in "Inje University Ilsan Paik Hospital". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Inje University Ilsan Paik Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Inje University Ilsan Paik Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 3 trials that are defined as “Not Applicable".

Inje University Ilsan Paik Hospital has several departments that took part in Clinical trials: "Inje University Busan Paik Hospital; Nephrology" - 2 trials, "Department of Neurology,Sanggye Paik Hospital, Inje University College of Medicine" - 2 trials, "Department of Surgery, Breast Cancer Center, Inje University Paik Hospital" - 2 trials